Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey.
Parent survey hints at a link between post-MMR acetaminophen and autism, yet the evidence is weak and purely correlational.
01Research in Context
What this study did
Parents of the kids with autism filled out a survey. They answered questions about giving acetaminophen right after the MMR shot.
The team also asked parents of kids without autism. They compared the two groups to look for patterns.
What they found
Kids who got acetaminophen after the MMR were more likely to have an autism label. The link showed up only in certain subgroups, not across the whole sample.
The study cannot prove the medicine caused autism. It only points to a possible correlation that needs real testing.
How this fits with other research
Howard et al. (2023) built a better way to watch autism signs. Their SOAR scale watches toddlers play and scores sensory behaviors live. This moves us past shaky parent memory.
Kraijer et al. (2005) already gave us a quick 15-item screen for autism in people with intellectual disability. Their tool works across ages and sensory impairments, showing good assessment is possible.
Noroozi et al. (2016) hunted for gene links instead of drug links. They found one version of the GRM7 gene tied to autism, reminding us biology is complex and many factors may matter.
Why it matters
This paper is a yellow flag, not a stop sign. Share the finding with families, but stress that parent surveys are weak evidence. Keep using acetaminophen when fever control is needed after vaccines. Watch for stronger designs—like prospective trials—before changing practice.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →If a parent asks about this study, explain the difference between a survey link and proven cause, then refer them to their pediatrician for medical advice.
02At a glance
03Original abstract
The present study was performed to determine whether acetaminophen (paracetamol) use after the measles-mumps-rubella vaccination could be associated with autistic disorder. This case-control study used the results of an online parental survey conducted from 16 July 2005 to 30 January 2006, consisting of 83 children with autistic disorder and 80 control children. Acetaminophen use after measles-mumps-rubella vaccination was significantly associated with autistic disorder when considering children 5 years of age or less (OR 6.11, 95% CI 1.42-26.3), after limiting cases to children with regression in development (OR 3.97, 95% CI 1.11-14.3), and when considering only children who had post-vaccination sequelae (OR 8.23, 95% CI 1.56-43.3), adjusting for age, gender, mother's ethnicity, and the presence of illness concurrent with measles-mumps-rubella vaccination. Ibuprofen use after measles-mumps-rubella vaccination was not associated with autistic disorder. This preliminary study found that acetaminophen use after measles-mumps-rubella vaccination was associated with autistic disorder.
Autism : the international journal of research and practice, 2008 · doi:10.1177/1362361307089518